#USA #Washington #PETA #Long-Tailed Macaques #USFWS

U.S. Fish and Wildlife Service's Rejection of Long-tailed Macaque Petition

On July 14, 2026, the U.S. Fish and Wildlife Service (USFWS) declined a petition submitted by People for the Ethical Treatment of Animals (PETA) and other activist groups to classify long-tailed macaques (Macaca fascicularis) as endangered under the Endangered Species Act (ESA). This is the second time in three years that the agency has turned down such a request, raising questions about the motivations of activist groups concerning animal welfare policies.

In its evaluation, the USFWS determined that the petition lacked substantial scientific data that would warrant further review. Matthew R. Bailey, the president of the National Association for Biomedical Research (NABR), commended the USFWS for conducting a thorough examination based on scientific evidence and concluded that long-tailed macaques do not require listing under the ESA.

Bailey emphasized that it is evident that activist groups, such as PETA, may seek to use endangered species legislation as a means to obstruct medical research in the United States and globally. He pointed out that such actions could jeopardize human health and safety, undermining both the legitimacy of environmental processes and the research and development of medical treatments crucial for mankind.

The long-tailed macaque is an integral component of biomedical research largely because of their similarities to humans. Their use in the field is strictly regulated by international norms and U.S. federal agencies. Research involving these primates has been instrumental in breakthroughs across various domains, including regenerative medicine, immunology, oncology, vaccine development, and pharmacology.

Recent studies published by the National Institutes of Health (NIH) reinforced the pivotal role of long-tailed macaques in biomedical research. As Bailey noted, their physiological and biological similarities to humans make them an essential resource for preclinical studies, contributing to the development of treatments that precede clinical trials.

In light of their undeniable contributions, long-tailed macaques have played a critical role in advancing numerous current medications and treatments, showcasing their invaluable position within the biomedical community. The NABR has reaffirmed its commitment to safeguarding the integrity of medical research while ensuring that decisions around species protection are made based on the most accurate scientific data.

The ongoing discourse surrounding the classification of long-tailed macaques reveals the complex interplay between animal rights activism and public health initiatives. As the scientific community continues to navigate these waters, it becomes increasingly critical to distinguish between genuine conservation efforts and actions that may inadvertently hinder crucial medical research efforts.

Going forward, the NABR expresses its intention to actively engage in the policy-making process to ensure that ethical considerations underpin sound scientific research practices. While the debate around the protection of various species will continue, it is essential to prioritize human health and welfare as well.

In conclusion, the USFWS's decision reflects a commitment to evidence-based policy-making, affirming the importance of rigorous scientific scrutiny in discussions about endangered species. As developments unfold, maintaining an open dialogue between scientists, activists, and policymakers will be vital in ensuring that both animal welfare and public health interests are respected.

About the National Association for Biomedical Research

Founded in 1979, the National Association for Biomedical Research (NABR) is a dedicated nonprofit organization focusing on developing policies favoring the humane use of animals in biomedical research, education, and testing. It comprises over 280 institutions, including universities, veterinary schools, pharmaceutical companies, and patient advocacy groups that rely on responsible animal research to enhance human and animal health worldwide. For more information about NABR's mission and initiatives, please visit www.nabr.org.